- Previous Close
2.4700 - Open
2.5650 - Bid --
- Ask --
- Day's Range
2.4900 - 2.5650 - 52 Week Range
1.7500 - 4.3870 - Volume
32,896 - Avg. Volume
86,619 - Market Cap (intraday)
175.248M - Beta (5Y Monthly) 0.93
- PE Ratio (TTM)
-- - EPS (TTM)
-0.4500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
8.75
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, together with its subsidiaries, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.
www.alphatau.comRecent News: DRTS
View More
Performance Overview: DRTS
Trailing total returns as of 4/8/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DRTS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRTS
View MoreValuation Measures
Market Cap
175.25M
Enterprise Value
128.18M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.80
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-23.27%
Return on Equity (ttm)
-43.16%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-31.75M
Diluted EPS (ttm)
-0.4500
Balance Sheet and Cash Flow
Total Cash (mrq)
59.6M
Total Debt/Equity (mrq)
20.00%
Levered Free Cash Flow (ttm)
-12.97M